SEC 13F Intelligence

Argyle Capital Management, LLC / LLY

Argyle Capital Management, LLC’s Eli Lilly & Co Position

Does Argyle Capital Management, LLC own Eli Lilly & Co (LLY)? Yes — 10.8K shares worth $10M (+3.22% of its 13F portfolio) as of Q1 2026, down from 11.1K shares the prior filed quarter.

Position Value
$10M
Q1 2026
Shares
10.8K
% of Portfolio
+3.22%
Quarters Held
30
currently held

Position History LLY

Reported value by quarter
Q4 ’18: $4MQ4 ’18Q1 ’19: $5MQ2 ’19: $4MQ3 ’19: $4MQ4 ’19: $5MQ4 ’19Q1 ’20: $5MQ2 ’20: $5MQ3 ’20: $5MQ4 ’20: $5MQ4 ’20Q1 ’21: $5MQ2 ’21: $7MQ3 ’21: $7MQ4 ’21: $8MQ4 ’21Q1 ’22: $8MQ2 ’22: $9MQ3 ’22: $8MQ4 ’22: $9MQ4 ’22Q1 ’23: $8MQ2 ’23: $11MQ3 ’23: $12MQ4 ’23: $11MQ4 ’23Q1 ’24: $11MQ2 ’24: $11MQ3 ’24: $10MQ4 ’24: $9MQ4 ’24Q1 ’25: $10MQ2 ’25: $9MQ3 ’25: $8MQ4 ’25: $12MQ4 ’25Q1 ’26: $10Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 202610.8K$10M+3.22%
Q4 202511.1K$12M+3.97%
Q3 202511.1K$8M+2.93%
Q2 202511.1K$9M+3.14%
Q1 202511.5K$10M+3.53%
Q4 202411.5K$9M+3.51%
Q3 202411.5K$10M+4.07%
Q2 202412.6K$11M+4.70%
Q1 202414.0K$11M+4.22%
Q4 202318.5K$11M+4.46%
Q3 202322.2K$12M+4.36%
Q2 202322.9K$11M+3.87%
Q1 202324.1K$8M+2.91%
Q4 202225.1K$9M+3.15%
Q3 202225.5K$8M+3.21%
Q2 202226.3K$9M+3.06%
Q1 202226.5K$8M+2.47%
Q4 202127.6K$8M+2.38%
Q3 202128.1K$7M+2.15%
Q2 202128.3K$7M+2.10%
Q1 202128.7K$5M+1.81%
Q4 202029.7K$5M+1.87%
Q3 202030.9K$5M+1.87%
Q2 202031.2K$5M+2.15%
Q1 202036.6K$5M+2.40%
Q4 201936.7K$5M+1.71%
Q3 201937.2K$4M+1.57%
Q2 201937.5K$4M+1.58%
Q1 201937.5K$5M+1.87%
Q4 201837.6K$4M+1.84%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Argyle Capital Management, LLC’s full portfolio or all institutional holders of LLY.